Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

Egypt. J. Exp. Biol. (Zoo.). 2007; 3(0): 171-178


CORRELATIVE STUDY OF SERUM P53, CARCINOEMBRYONIC ANTIGEN AND EPIDERMAL GROWTH FACTOR RECEPTOR IN COLORECTAL CANCER PATIENTS

Ibrahim M. El-Kady.




Abstract

Enzyme-linked immunosorbent assay (ELISA) was used for analysis of serum mutant p53 protein and epidermal growth factor receptor (EGFR) and electrochem-iluminescence immunoassay (ECLIA) was used for analysis of carcinoembryonic antigen (CEA). Serum samples were obtained from 48 patients with colorectal cancer (CRC) and a control group of twenty healthy individuals. The results demonstrated a significant increase of serum mutant p53, EGFR, and CEA levels in CRC patients compared to the control group (P < 0.001for each). Mutant p53 protein was significantly different in the different CRC grades (P = 0.028). p53, CEA, and EGFR can differentiate successfully between different CRC Duke's stages and normal control (P < 0.001 for each).Sensitivities of p53, CEA, and EGFR were 39.6, 31, and 71%, respectively. There was no correlation between CEA, EGFR and p53 indicating that these variables were independent. Positive status of serum CEA and/or p53 was found in 29 out of 48 (60%) patients. Also, positive status of serum CEA and/or EGFR was found in 39 out of 48 (81%) patients. The simultaneous determination of p53 or EGFR combined with CEA may increase the sensitivity to diagnose CRC patients and may aid in disease prognosis.

Key words: EGFR; CEA; Colorectal carcinoma; Mutant p53 protein; Area under curve variables; Monoclonal antibodies; Tyrosine kinase activity.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.